Gregory S. Wellman
Gregory S. Wellman publishes mostly in Economics and Econometrics, Public Health, Environmental and Occupational Health and Pharmacology, on topics such as Pharmaceutical Economics and Policy, Pharmaceutical Practices and Patient Outcomes and Pharmaceutical industry and healthcare.
- World rank
- #4,248,068 of 7,710,434 ranked researchers
- Rank in United States
- #1,144,653 of 1,627,098
- Works
- 27
- Citations
- 265
- Citations per work
- 9.8
What does Gregory S. Wellman research?
Gregory S. Wellman's work is mostly in Medicine (18%), Economics, Econometrics and Finance (12%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1658.9%
- Health Sciences623.3%
- Medicine517.8%
- Health Professions15.5%
- Social Sciences312.3%
- Life Sciences15.5%
- 1Economics and Econometrics12% of their works
- 2Public Health, Environmental and Occupational Health8% of their works
- 3Pharmacology6% of their works
- 4General Health Professions6% of their works
- 5Geriatrics and Gerontology6% of their works
- 6Gastroenterology4% of their works
Research topics
- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical industry and healthcare
- Antibiotic Use and Resistance
- Safe Handling of Antineoplastic Drugs
- Medication Adherence and Compliance
- Gastrointestinal Tumor Research and Treatment
- Pharmaceutical studies and practices
Which keywords describe Gregory S. Wellman's research?
The keywords of their largest research topics: Pharmaceutical Industry, Clinical Trials, Drug Development Costs, Generic Drugs, Inappropriate Medication Use, Medication Adherence, Polypharmacy and Conflict of Interest.
- Sunitinib
- Patient Compliance
- Occupational Exposure
- Antineoplastic Drugs
- Antibiotic Resistance
- Conflict of Interest
- Medication Adherence
- Generic Drugs
- Clinical Trials
- Pharmaceutical Industry
- Drug Development Costs
- Inappropriate Medication Use
- Polypharmacy
- Research Outcome
- Antimicrobial Stewardship
- Imatinib Mesylate
- Off-Label Drug Use
- Pediatric Pharmacokinetics
- Treatment Adherence
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Pharmaceutical Industry82 topics
- Clinical Trials52 topics
- Drug Development Costs51 topic
- Generic Drugs51 topic
- Inappropriate Medication Use41 topic
- Medication Adherence42 topics
- Polypharmacy41 topic
- Conflict of Interest31 topic
- Research Outcome31 topic
- Antibiotic Resistance21 topic
- Antimicrobial Stewardship21 topic
- Antineoplastic Drugs21 topic
- Imatinib Mesylate21 topic
- Occupational Exposure21 topic
- Off-Label Drug Use21 topic
- Patient Compliance21 topic
- Pediatric Pharmacokinetics21 topic
- Sunitinib21 topic
- Treatment Adherence21 topic
Where does Gregory S. Wellman work?
Gregory S. Wellman's main affiliation in the publication record is Ferris State University, United States.
How many publications and citations does Gregory S. Wellman have?
OpenAlex counts 27 works and 265 citations for Gregory S. Wellman, an h-index of 9, ranking #4,248,068 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gregory S. Wellman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.